162 related articles for article (PubMed ID: 15206238)
1. [Monoclonal antibodies and chemotherapy: therapeutic indications].
Carrozza F
Suppl Tumori; 2004; 3(4):S127-9. PubMed ID: 15206238
[No Abstract] [Full Text] [Related]
2. [Cancer immunotherapy: recent breakthroughs and perspectives].
Tartour E; Sandoval F; Bonnefoy JY; Fridman WH
Med Sci (Paris); 2011 Oct; 27(10):833-41. PubMed ID: 22027420
[TBL] [Abstract][Full Text] [Related]
3. Improving the efficacy of antibody-based cancer therapies.
Carter P
Nat Rev Cancer; 2001 Nov; 1(2):118-29. PubMed ID: 11905803
[TBL] [Abstract][Full Text] [Related]
4. [Use of new molecules in the treatment of advanced thyroid cancer].
Galofré JC; Gómez-Sáez JM; Álvarez Escola C; Álvarez García E; Anda Apiñaniz E; Calleja A; Donnay S; Lucas-Martin A; Menéndez Torre E; Navarro González E; Pereg V; Pérez Corral B; Santamaría Sandi J; Riesco Eizaguirre G; Zafón Llopis C;
Endocrinol Nutr; 2011 Oct; 58(8):381-6. PubMed ID: 21924966
[No Abstract] [Full Text] [Related]
5. The use of monoclonal antibody immunoconjugates in cancer therapy.
Pietersz GA; Krauer K; McKenzie IF
Adv Exp Med Biol; 1994; 353():169-79. PubMed ID: 7985535
[No Abstract] [Full Text] [Related]
6. Antibody Therapies in Cancer.
Wang S; Jia M
Adv Exp Med Biol; 2016; 909():1-67. PubMed ID: 27240456
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy's cancer remit widens.
Ledford H
Nature; 2013 May; 497(7451):544. PubMed ID: 23719439
[No Abstract] [Full Text] [Related]
8. [Monoclonal antibodies and chemotherapy: planning and management of symptoms].
Berardini R
Suppl Tumori; 2004; 3(4):S130-2. PubMed ID: 15206239
[No Abstract] [Full Text] [Related]
9. Advances in radiosensitization.
Lawrence TS
Clin Adv Hematol Oncol; 2004 Sep; 2(9):575-7. PubMed ID: 16163239
[No Abstract] [Full Text] [Related]
10. Interventions that induce modifications in the tumor microenvironment.
Bernhard EJ
Cancer Radiother; 2011 Aug; 15(5):376-82. PubMed ID: 21571567
[TBL] [Abstract][Full Text] [Related]
11. Genetically modified dendritic cells in cancer immunotherapy: a better tomorrow?
Shurin MR; Gregory M; Morris JC; Malyguine AM
Expert Opin Biol Ther; 2010 Nov; 10(11):1539-53. PubMed ID: 20955111
[TBL] [Abstract][Full Text] [Related]
12. Future prospects of monoclonal antibodies as magic bullets in immunotherapy.
Maleki LA; Baradaran B; Majidi J; Mohammadian M; Shahneh FZ
Hum Antibodies; 2013; 22(1-2):9-13. PubMed ID: 24284304
[TBL] [Abstract][Full Text] [Related]
13. Antibody-targeted immunotherapy for treatment of malignancy.
White CA; Weaver RL; Grillo-López AJ
Annu Rev Med; 2001; 52():125-45. PubMed ID: 11160771
[TBL] [Abstract][Full Text] [Related]
14. A target for tumour-directed therapy.
Hynes NE; Groner B
Nat Med; 1995 Jul; 1(7):631. PubMed ID: 7585140
[No Abstract] [Full Text] [Related]
15. Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers.
Pegram M; Hsu S; Lewis G; Pietras R; Beryt M; Sliwkowski M; Coombs D; Baly D; Kabbinavar F; Slamon D
Oncogene; 1999 Apr; 18(13):2241-51. PubMed ID: 10327070
[TBL] [Abstract][Full Text] [Related]
16. Gpnmb/osteoactivin, an attractive target in cancer immunotherapy.
Zhou LT; Liu FY; Li Y; Peng YM; Liu YH; Li J
Neoplasma; 2012; 59(1):1-5. PubMed ID: 22017590
[TBL] [Abstract][Full Text] [Related]
17. Biomarker targets and novel therapeutics.
Clouser M; Hess LM; Chambers SK
Cancer Treat Res; 2009; 149():85-105. PubMed ID: 19763432
[No Abstract] [Full Text] [Related]
18. Monoclonal antibodies for medical oncology: a few critical perspectives.
Belda-Iniesta C; Ibáñez de Cáceres I; de Castro J
Clin Transl Oncol; 2011 Feb; 13(2):84-7. PubMed ID: 21324795
[TBL] [Abstract][Full Text] [Related]
19. Remission of human breast cancer xenografts on therapy with humanized monoclonal antibody to HER-2 receptor and DNA-reactive drugs.
Pietras RJ; Pegram MD; Finn RS; Maneval DA; Slamon DJ
Oncogene; 1998 Oct; 17(17):2235-49. PubMed ID: 9811454
[TBL] [Abstract][Full Text] [Related]
20. Overview of monoclonal antibodies in cancer therapy: present and promise.
Stern M; Herrmann R
Crit Rev Oncol Hematol; 2005 Apr; 54(1):11-29. PubMed ID: 15780905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
